TegoScience Inc (191420) — Cash Flow-to-Debt Ratio
TegoScience Inc (191420) has a Cash Flow-to-Debt Ratio of -0.02x as of June 2026, meaning its operating cash flow of ₩-700.37 Million could theoretically repay 0% of its total liabilities (₩32.78 Billion) in one year. See 191420 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
TegoScience Inc Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for TegoScience Inc across 11 annual periods. For the full cash flow conversion analysis, see 191420 operating cash flow.
Annual Cash Flow-to-Debt Ratio for TegoScience Inc (2015–2025)
Year-by-year debt coverage analysis for TegoScience Inc. Check cash flow quality index of TegoScience Inc to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.11x | ₩-3.07 Billion | ₩27.83 Billion | ▲ +74.8% |
| 2024 | -0.44x | ₩-1.16 Billion | ₩2.66 Billion | ▼ -42.0% |
| 2023 | -0.31x | ₩-794.61 Million | ₩2.58 Billion | ▼ -181.8% |
| 2022 | 0.38x | ₩1.04 Billion | ₩2.77 Billion | ▲ +108.0% |
| 2021 | 0.18x | ₩457.25 Million | ₩2.53 Billion | ▼ -80.0% |
| 2020 | 0.91x | ₩1.28 Billion | ₩1.41 Billion | ▲ +1541.7% |
| 2019 | 0.06x | ₩41.40 Million | ₩750.71 Million | ▼ -94.2% |
| 2018 | 0.95x | ₩833.88 Million | ₩882.02 Million | ▲ +291.7% |
| 2017 | 0.24x | ₩2.87 Billion | ₩11.87 Billion | ▲ +91.1% |
| 2016 | 0.13x | ₩2.36 Billion | ₩18.66 Billion | ▼ -97.4% |
| 2015 | 4.77x | ₩2.63 Billion | ₩551.82 Million | — |